Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1994 Jul;53(7):434–439. doi: 10.1136/ard.53.7.434

Methotrexate-related pulmonary complications in rheumatoid arthritis.

P Barrera 1, R F Laan 1, P L van Riel 1, P N Dekhuijzen 1, A M Boerbooms 1, L B van de Putte 1
PMCID: PMC1005365  PMID: 7944614

Full text

PDF
435

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akoun G. M., Mayaud C. M., Touboul J. L., Denis M. F., Milleron B. J., Perrot J. Y. Use of bronchoalveolar lavage in the evaluation of methotrexate lung disease. Thorax. 1987 Sep;42(9):652–655. doi: 10.1136/thx.42.9.652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alarcón G. S., Tracy I. C., Blackburn W. D., Jr Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum. 1989 Jun;32(6):671–676. doi: 10.1002/anr.1780320603. [DOI] [PubMed] [Google Scholar]
  3. Altz-Smith M., Kendall L. G., Jr, Stamm A. M. Cryptococcosis associated with low-dose methotrexate for arthritis. Am J Med. 1987 Jul;83(1):179–181. doi: 10.1016/0002-9343(87)90517-1. [DOI] [PubMed] [Google Scholar]
  4. Anderson L. L., Collins G. J., Ojima Y., Sullivan R. D. A study of the distribution of methotrexate in human tissues and tumors. Cancer Res. 1970 May;30(5):1344–1348. [PubMed] [Google Scholar]
  5. Angier R. B., Boothe J. H., Hutchings B. L., Mowat J. H., Semb J., Stokstad E. L., Subbarow Y., Waller C. W., Cosulich D. B., Fahrenbach M. J., Hultquist M. E., Kuh E., Northey E. H., Seeger D. R., Sickels J. P., Smith J. M., Jr The Structure and Synthesis of the Liver L. casei Factor. Science. 1946 May 31;103(2683):667–669. doi: 10.1126/science.103.2683.667. [DOI] [PubMed] [Google Scholar]
  6. Bedrossian C. W., Miller W. C., Luna M. A. Methotrexate-induced diffuse interstitial pulmonary fibrosis. South Med J. 1979 Mar;72(3):313–318. doi: 10.1097/00007611-197903000-00023. [DOI] [PubMed] [Google Scholar]
  7. Bernstein M. L., Sobel D. B., Wimmer R. S. Noncardiogenic pulmonary edema following injection of methotrexate into the cerebrospinal fluid. Cancer. 1982 Sep 1;50(5):866–868. doi: 10.1002/1097-0142(19820901)50:5<866::aid-cncr2820500510>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  8. Bisson G., Drapeau G., Lamoureux G., Cantin A., Rola-Pleszczynski M., Bégin R. Computer-based quantitative analysis of gallium-67 uptake in normal and diseased lungs. Chest. 1983 Nov;84(5):513–517. doi: 10.1378/chest.84.5.513. [DOI] [PubMed] [Google Scholar]
  9. Boerbooms A. M., Jeurissen M. E., Westgeest A. A., Theunisse H., Van de Putte L. B. Methotrexate in refractory rheumatoid arthritis. Clin Rheumatol. 1988 Jun;7(2):249–256. doi: 10.1007/BF02204463. [DOI] [PubMed] [Google Scholar]
  10. Boh L. E., Schuna A. A., Pitterle M. E., Adams E. M., Sundstrom W. R. Low-dose weekly oral methotrexate therapy for inflammatory arthritis. Clin Pharm. 1986 Jun;5(6):503–508. [PubMed] [Google Scholar]
  11. Buchbinder R., Hall S., Sambrook P. N., Champion G. D., Harkness A., Lewis D., Littlejohn G. O., Miller M. H., Ryan P. F. Methotrexate therapy in rheumatoid arthritis: a life table review of 587 patients treated in community practice. J Rheumatol. 1993 Apr;20(4):639–644. [PubMed] [Google Scholar]
  12. Cannon G. W. Pulmonary complications of antirheumatic drug therapy. Semin Arthritis Rheum. 1990 Jun;19(6):353–364. doi: 10.1016/0049-0172(90)90072-n. [DOI] [PubMed] [Google Scholar]
  13. Cannon G. W., Ward J. R., Clegg D. O., Samuelson C. O., Jr, Abbott T. M. Acute lung disease associated with low-dose pulse methotrexate therapy in patients with rheumatoid arthritis. Arthritis Rheum. 1983 Oct;26(10):1269–1274. doi: 10.1002/art.1780261015. [DOI] [PubMed] [Google Scholar]
  14. Carson C. W., Cannon G. W., Egger M. J., Ward J. R., Clegg D. O. Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate. Semin Arthritis Rheum. 1987 Feb;16(3):186–195. doi: 10.1016/0049-0172(87)90021-7. [DOI] [PubMed] [Google Scholar]
  15. Clarysse A. M., Cathey W. J., Cartwright G. E., Wintrobe M. M. Pulmonary disease complicating intermittent therapy with methotrexate. JAMA. 1969 Sep 22;209(12):1861–1868. [PubMed] [Google Scholar]
  16. Clerc D., Brousse C., Mariette X., Bennet P., Bisson M. Cytomegalovirus pneumonia in a patient with rheumatoid arthritis treated with low dose methotrexate and prednisone. Ann Rheum Dis. 1991 Jan;50(1):67–67. doi: 10.1136/ard.50.1.67-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Cook N. J., Carroll G. J. Successful reintroduction of methotrexate after pneumonitis in two patients with rheumatoid arthritis. Ann Rheum Dis. 1992 Feb;51(2):272–274. doi: 10.1136/ard.51.2.272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. De Bandt M., Rat A. C., Palazzo E., Kahn M. F. Delayed methotrexate pneumonitis. J Rheumatol. 1991 Dec;18(12):1943–1943. [PubMed] [Google Scholar]
  19. Dickey B. F., Myers A. R. Pulmonary disease in polymyositis/dermatomyositis. Semin Arthritis Rheum. 1984 Aug;14(1):60–76. doi: 10.1016/0049-0172(84)90010-6. [DOI] [PubMed] [Google Scholar]
  20. Drosos A. A., Psychos D., Andonopoulos A. P., Stefanaki-Nikou S., Tsianos E. B., Moutsopoulos H. M. Methotrexate therapy in rheumatoid arthritis. A two year prospective follow-up. Clin Rheumatol. 1990 Sep;9(3):333–341. doi: 10.1007/BF02114393. [DOI] [PubMed] [Google Scholar]
  21. Elsasser S., Dalquen P., Soler M., Perruchoud A. P. Methotrexate-induced pneumonitis: appearance four weeks after discontinuation of treatment. Am Rev Respir Dis. 1989 Oct;140(4):1089–1092. doi: 10.1164/ajrccm/140.4.1089. [DOI] [PubMed] [Google Scholar]
  22. Engelbrecht J. A., Calhoon S. L., Scherrer J. J. Methotrexate pneumonitis after low-dose therapy for rheumatoid arthritis. Arthritis Rheum. 1983 Oct;26(10):1275–1278. doi: 10.1002/art.1780261016. [DOI] [PubMed] [Google Scholar]
  23. Flood D. A., Chan C. K., Pruzanski W. Pneumocystis carinii pneumonia associated with methotrexate therapy in rheumatoid arthritis. J Rheumatol. 1991 Aug;18(8):1254–1256. [PubMed] [Google Scholar]
  24. Furst D. E., Erikson N., Clute L., Koehnke R., Burmeister L. F., Kohler J. A. Adverse experience with methotrexate during 176 weeks of a longterm prospective trial in patients with rheumatoid arthritis. J Rheumatol. 1990 Dec;17(12):1628–1635. [PubMed] [Google Scholar]
  25. GUBNER R., AUGUST S., GINSBERG V. Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis. Am J Med Sci. 1951 Feb;221(2):176–182. [PubMed] [Google Scholar]
  26. Gaensler E. A., Carrington C. B. Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients. Ann Thorac Surg. 1980 Nov;30(5):411–426. doi: 10.1016/s0003-4975(10)61291-x. [DOI] [PubMed] [Google Scholar]
  27. Grubben M. J., Kerstens P. J., Wiersma J. M., Boerbooms A. M., Festen J. Pleuro-pulmonary involvement in patients with connective tissue disease. The role of open lung biopsy. Neth J Med. 1993 Dec;43(5-6):269–276. [PubMed] [Google Scholar]
  28. Gutin P. H., Green M. R., Bleyer W. A., Bauer V. L., Wiernik P. H., Walker M. D. Methotrexate pneumonitis induced by intrathecal methotrexate therapy: a case report with pharmacokinetic data. Cancer. 1976 Oct;38(4):1529–1534. doi: 10.1002/1097-0142(197610)38:4<1529::aid-cncr2820380414>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  29. Hansell D. M., Kerr I. H. The role of high resolution computed tomography in the diagnosis of interstitial lung disease. Thorax. 1991 Feb;46(2):77–84. doi: 10.1136/thx.46.2.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Hargreaves M. R., Mowat A. G., Benson M. K. Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports. Thorax. 1992 Aug;47(8):628–633. doi: 10.1136/thx.47.8.628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kerstens P. J., Van Loenhout J. W., Boerbooms A. M., Van De Putte L. B. Methotrexate, pneumonitis, and infection. Ann Rheum Dis. 1992 Oct;51(10):1179–1180. doi: 10.1136/ard.51.10.1179-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kremer J. M., Phelps C. T. Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months. Arthritis Rheum. 1992 Feb;35(2):138–145. doi: 10.1002/art.1780350203. [DOI] [PubMed] [Google Scholar]
  33. Lang B., Riegel W., Peters T., Peter H. H. Low dose methotrexate therapy for rheumatoid arthritis complicated by pancytopenia and Pneumocystis carinii pneumonia. J Rheumatol. 1991 Aug;18(8):1257–1259. [PubMed] [Google Scholar]
  34. Lascari A. D., Strano A. J., Johnson W. W., Collins J. G. Methotrexate-induced sudden fatal pulmonary reaction. Cancer. 1977 Oct;40(4):1393–1397. doi: 10.1002/1097-0142(197710)40:4<1393::aid-cncr2820400405>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  35. Leff R. L., Case J. P. Rheumatoid arthritis, methotrexate therapy, and Pneumocystis pneumonia. Ann Intern Med. 1990 May 1;112(9):716–716. doi: 10.7326/0003-4819-112-9-716_1. [DOI] [PubMed] [Google Scholar]
  36. Massin F., Coudert B., Marot J. P., Foucher P., Camus P., Jeannin L. La pneumopathie du méthotrexate. Rev Mal Respir. 1990;7(1):5–15. [PubMed] [Google Scholar]
  37. Meenan R. F., Kazis L. E., Anthony J. M., Wallin B. A. The clinical and health status of patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 1991 Jun;34(6):761–765. doi: 10.1002/art.1780340618. [DOI] [PubMed] [Google Scholar]
  38. Padley S. P., Adler B., Hansell D. M., Müller N. L. High-resolution computed tomography of drug-induced lung disease. Clin Radiol. 1992 Oct;46(4):232–236. doi: 10.1016/s0009-9260(05)80161-8. [DOI] [PubMed] [Google Scholar]
  39. Pasquinucci G., Ferrara P., Castellari R. Daunorubicin treatment of methotrexate pneumonia. JAMA. 1971 Jun 21;216(12):2017–2017. doi: 10.1001/jama.1971.03180380071026. [DOI] [PubMed] [Google Scholar]
  40. Perruquet J. L., Harrington T. M., Davis D. E. Pneumocystis carinii pneumonia following methotrexate therapy for rheumatoid arthritis. Arthritis Rheum. 1983 Oct;26(10):1291–1292. doi: 10.1002/art.1780261021. [DOI] [PubMed] [Google Scholar]
  41. Pourel J., Guillemin F., Fener P., Webanck L., Bene M. C., Delorme N. Delayed methotrexate pneumonitis in rheumatoid arthritis. J Rheumatol. 1991 Feb;18(2):303–304. [PubMed] [Google Scholar]
  42. Schoenfeld A., Mashiach R., Vardy M., Ovadia J. Methotrexate pneumonitis in nonsurgical treatment of ectopic pregnancy. Obstet Gynecol. 1992 Sep;80(3 Pt 2):520–521. [PubMed] [Google Scholar]
  43. Scully C. J., Anderson C. J., Cannon G. W. Long-term methotrexate therapy for rheumatoid arthritis. Semin Arthritis Rheum. 1991 Apr;20(5):317–331. doi: 10.1016/0049-0172(91)90032-u. [DOI] [PubMed] [Google Scholar]
  44. Searles G., McKendry R. J. Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature. J Rheumatol. 1987 Dec;14(6):1164–1171. [PubMed] [Google Scholar]
  45. Shiroky J. B., Frost A., Skelton J. D., Haegert D. G., Newkirk M. M., Neville C. Complications of immunosuppression associated with weekly low dose methotrexate. J Rheumatol. 1991 Aug;18(8):1172–1175. [PubMed] [Google Scholar]
  46. Singh G., Fries J. F., Williams C. A., Zatarain E., Spitz P., Bloch D. A. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis. J Rheumatol. 1991 Feb;18(2):188–194. [PubMed] [Google Scholar]
  47. Sostman H. D., Matthay R. A., Putman C. E., Smith G. J. Methotrexate-induced pneumonitis. Medicine (Baltimore) 1976 Sep;55(5):371–388. doi: 10.1097/00005792-197609000-00002. [DOI] [PubMed] [Google Scholar]
  48. St Clair E. W., Rice J. R., Snyderman R. Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritis. Arch Intern Med. 1985 Nov;145(11):2035–2038. doi: 10.1001/archinte.145.11.2035. [DOI] [PubMed] [Google Scholar]
  49. Suzuki K., Rahman S. G., Akoun G. M. [Leukocyte migration inhibition test in drug-induced pneumonitis]. Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Jan;30(1):76–81. [PubMed] [Google Scholar]
  50. Tsai J. J., Shin J. F., Chen C. H., Wang S. R. Methotrexate pneumonitis in bronchial asthma. Int Arch Allergy Immunol. 1993;100(3):287–290. doi: 10.1159/000236426. [DOI] [PubMed] [Google Scholar]
  51. Tugwell P., Bennett K., Bell M., Gent M. Methotrexate in rheumatoid arthritis. Feedback on American College of Physicians guidelines. Ann Intern Med. 1989 Apr 15;110(8):581–583. doi: 10.7326/0003-4819-110-8-581. [DOI] [PubMed] [Google Scholar]
  52. Weinblatt M. E., Weissman B. N., Holdsworth D. E., Fraser P. A., Maier A. L., Falchuk K. R., Coblyn J. S. Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update. Arthritis Rheum. 1992 Feb;35(2):129–137. doi: 10.1002/art.1780350202. [DOI] [PubMed] [Google Scholar]
  53. Weinstein A., Marlowe S., Korn J., Farouhar F. Low-dose methotrexate treatment of rheumatoid arthritis. Long-term observations. Am J Med. 1985 Sep;79(3):331–337. doi: 10.1016/0002-9343(85)90312-2. [DOI] [PubMed] [Google Scholar]
  54. White D. A., Rankin J. A., Stover D. E., Gellene R. A., Gupta S. Methotrexate pneumonitis. Bronchoalveolar lavage findings suggest an immunologic disorder. Am Rev Respir Dis. 1989 Jan;139(1):18–21. doi: 10.1164/ajrccm/139.1.18. [DOI] [PubMed] [Google Scholar]
  55. Wijnands M. J., van't Hof M. A., van Leeuwen M. A., van Rijswijk M. H., van de Putte L. B., van Riel P. L. Long-term second-line treatment: a prospective drug survival study. Br J Rheumatol. 1992 Apr;31(4):253–258. doi: 10.1093/rheumatology/31.4.253. [DOI] [PubMed] [Google Scholar]
  56. Wollner A., Mohle-Boetani J., Lambert R. E., Perruquet J. L., Raffin T. A., McGuire J. L. Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis. Thorax. 1991 Mar;46(3):205–207. doi: 10.1136/thx.46.3.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. van den Hoogen F. H., Boerbooms A. M., van de Putte L. B., Rasker J. J., van Venrooij W. J. Low dose methotrexate treatment in systemic sclerosis. J Rheumatol. 1991 Nov;18(11):1763–1764. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES